Did Amarex blow it again? For phase 2 of our Ph
Post# of 148278
(Total Views: 631)
Posted On: 08/22/2021 2:16:32 PM
Did Amarex blow it again?
For phase 2 of our Phase 1/2 mTNBC trial the only primary outcome is listed as follows.
Phase II: Progression free survival (PFS) defined as time in months from the date of first study treatment to the date of disease progression or death from any cause, whichever comes first. [ Time Frame: Every 6 to 9 weeks after study start, until progression or death, assessed up to 2 years after completion of treatment ]
So mOS was not included in a 2-year long study! Yet it's in mOS LL shows or has a promise of much better results than SG, let alone SOC while showing at best similar results as SG in PFS.
For phase 2 of our Phase 1/2 mTNBC trial the only primary outcome is listed as follows.
Phase II: Progression free survival (PFS) defined as time in months from the date of first study treatment to the date of disease progression or death from any cause, whichever comes first. [ Time Frame: Every 6 to 9 weeks after study start, until progression or death, assessed up to 2 years after completion of treatment ]
So mOS was not included in a 2-year long study! Yet it's in mOS LL shows or has a promise of much better results than SG, let alone SOC while showing at best similar results as SG in PFS.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼